These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 23666631)
1. Stable renal engraftment in a patient following successful tandem autologous/reduced-intensity conditioning allogeneic transplantation for treatment of multiple myeloma with del(17p) that developed as a post-transplantation lymphoproliferative disease following renal transplantation. Aoki T; Kasai M; Harada Y; Matsubara E; Morishita T; Suzuki T; Tsujita M; Goto N; Katayama A; Watarai Y; Uchida K; Ito M; Saji H; Tsuzuki T; Uchida T; Ogura M Int J Hematol; 2013 Jul; 98(1):129-34. PubMed ID: 23666631 [TBL] [Abstract][Full Text] [Related]
2. Non-myeloablative allogeneic peripheral stem cell transplantation for multiple myeloma. Ma SY; Lie AK; Au WY; Chim CS; Kwong YL; Liang R Hong Kong Med J; 2004 Apr; 10(2):77-83. PubMed ID: 15075426 [TBL] [Abstract][Full Text] [Related]
3. Twenty-year Follow-up of Histocompatibility Leukocyte Antigen-matched Kidney and Bone Marrow Cotransplantation for Multiple Myeloma With End-stage Renal Disease: Lessons Learned. Spitzer TR; Tolkoff-Rubin N; Cosimi AB; McAfee S; Dey BR; Chen YB; Delmonico F; Sykes M; Sachs DH; Kawai T Transplantation; 2019 Nov; 103(11):2366-2372. PubMed ID: 30801529 [TBL] [Abstract][Full Text] [Related]
4. Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma. Maffini E; Storer BE; Sandmaier BM; Bruno B; Sahebi F; Shizuru JA; Chauncey TR; Hari P; Lange T; Pulsipher MA; McSweeney PA; Holmberg L; Becker PS; Green DJ; Mielcarek M; Maloney DG; Storb R Haematologica; 2019 Feb; 104(2):380-391. PubMed ID: 30262560 [TBL] [Abstract][Full Text] [Related]